TRP Summit 2020

  • Exploring new radiopharmaceuticals
  • Sourcing radiopharmaceuticals supply to secure trials
  • Developing radionuclide therapy using molecular imaging

Countdown

Days
Hours
Minutes
Seconds

Digital Summit

The Targeted Radiopharmaceuticals (TRP) Summit: an industry-led platform that discusses challenges and opportunities faced by developers of theranostic radio ligand therapies. Topics such as the identification and validation of new targets and ways to improve the current clinical design methodologies will be discussed by speakers and panels.

For the 2021 edition of this conference, it is possible to  attend either in-person in Berlin or remotely via a dedicated digital networking platform with all the access to the conference content. 

 

Visit our booth!

Programme

  • Jan van Bodegom will speak on behalf of FIELD-LAB about the future of effective cancer therapy using alpha emitting isotopes. He will discuss how to avoid delayed damage, the ideal half-life for effectiveness with minimal side effects and how to secure a reliable supply chain of essential medical isotopes. He will also address the role of FIELD-LAB in advancing the discovery and development of promising new radiopharmaceuticals.
  • NRG will be present in Berlin hosting a booth where you can meet our Business development colleagues.
  • Further information about FIELD-LAB and its current projects can be found via NRG’s digital booth .
  • Our team is available for appointments, which can be scheduled via this digital booth or by leaving your contact information in the form below on this page.
Jan Van Bodegom

Jan van Bodegom
Chief Executive Officer Coretag

Speaker: Jan van Bodegom

Jan van Bodegom has vast experience in the medical field, from working as a surgeon to healthcare management and the development of medical devices. In 2000, he graduated from Erasmus University Medical School in Rotterdam as a surgeon and went on to work in Bernhoven Hospital in Uden, the Netherlands, for 10 years. He founded the Alexander Monro Hospital, the first breast cancer hospital in Europe and he co-founded the first focus clinic for prostate cancer: Reinier Haga Prostate Cancer Center, Delft.

He is the CEO of Coretag, a company specialized in developing radio ligands, which detect and target necrotic cells in the body.

“Accelerated availability of targeted alpha therapy for patients can make a real difference”

Our current projects

drag for more
EANM 2020

Lutetium-177 n.c.a.

  • Medical isotope in high demand
  • Beta-emitter
  • Independent supply from in-house FIELD-LAB process
More Information
EANM 2020

Pt-195m CISSPECT

  • High quality
  • Chemotherapeutic compound (cisplatin) with Pt-195m integrated by synthesis
  • For in-human use
  • Chemotherapeutic function unaltered
More Information
EANM 2020

Lead-212

  • Beta-emitter with limited recoil, and a single alpha emission in the decay chain
  • Ideal half-life (~10 hrs.)
  • Reliable supply
More Information
Nrg FIELD LAB

  • Medical product development
  • Unique nuclear infrastructure
  • Supply of promising medical isotopes
More Information
Go to research

Practical information

When:             Tuesday 7 until Thursday 9, December 2021

Where:            Berlin and online 

If you wish to learn more about the speakers, the programme or registration, please check the TRP Summit website. 

 

TRP Summit

Contactform

We look forward to meet you in Berlin or online!

If you want to get in touch about the TRP Summit or want to learn more about FIELD-LAB and Advancing Nuclear Medicine, please leave your contact information in this form. We will reach out to you as soon as possible. 

Contact

Tel.: +31 (0)224 56 4950

Address Petten
Westerduinweg 3, 1755 LE Petten, Nederland

Address Arnhem
Utrechtseweg 310 B50-West, 6812 AR Arnhem, Nederland

Go to

NRG ENP